Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology. Part 2: Propellane derivatives with an amide side chain.

[1]  H. Nagase,et al.  Synthesis of quinolinomorphinan-4-ol derivatives as δ opioid receptor agonists. , 2012, Bioorganic & medicinal chemistry.

[2]  H. Nagase,et al.  Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology: part 1. , 2011, Bioorganic & medicinal chemistry letters.

[3]  H. Nagase,et al.  Opioids in preclinical and clinical trials. , 2011, Topics in current chemistry.

[4]  H. Nagase,et al.  Design and synthesis of KNT-127, a δ-opioid receptor agonist effective by systemic administration. , 2010, Bioorganic & medicinal chemistry letters.

[5]  N. Yamaotsu,et al.  Identification of the three-dimensional pharmacophore of kappa-opioid receptor agonists. , 2010, Bioorganic & medicinal chemistry.

[6]  N. Yamaotsu,et al.  3D-Pharmacophore Identification for κ-Opioid Agonists Using Ligand-Based Drug-Design Techniques , 2010 .

[7]  N. Yamaotsu,et al.  Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology. , 2010, Bioorganic & medicinal chemistry letters.

[8]  S. Hirono,et al.  Design and synthesis of novel delta opioid receptor agonists and their pharmacologies. , 2009, Bioorganic & medicinal chemistry letters.

[9]  H. Mochizuki,et al.  Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients. , 2009, Drugs of today.

[10]  M. Narita,et al.  Synthesis of a novel 6,14-epoxymorphinan derivative and its pharmacology. , 2008, Bioorganic & medicinal chemistry letters.

[11]  H. Nagase,et al.  Design, synthesis, and structure-activity relationship of novel opioid kappa-agonists. , 2008, Bioorganic & medicinal chemistry.

[12]  S. Hirono,et al.  Synthesis of a stable iminium salt and propellane derivatives. , 2008, The Journal of organic chemistry.

[13]  M. Narita,et al.  Differential properties between TRK-820 and U-50,488H on the discriminative stimulus effects in rats. , 2004, Life sciences.

[14]  Ronald F. Mucha,et al.  Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning , 2004, Psychopharmacology.

[15]  J. Kamei,et al.  The pharmacological profile of δ opioid receptor ligands, (+) and (−) TAN-67 on pain modulation , 2001 .

[16]  M. Narita,et al.  The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice. , 2001, Life sciences.

[17]  M. Narita,et al.  The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice. , 2000, European journal of pharmacology.

[18]  J. Kamei,et al.  Characterization of the antinociceptive effects of TRK-820 in the rat. , 2000, European journal of pharmacology.

[19]  M. Narita,et al.  Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist , 1999 .

[20]  H. Nagase,et al.  Rational drug design and synthesis of a highly selective nonpeptide delta-opioid agonist, (4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl- 1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine (TAN-67). , 1998, Chemical & pharmaceutical bulletin.

[21]  H. Nagase,et al.  Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan. , 1998, Chemical & pharmaceutical bulletin.

[22]  Shuichi Hirono,et al.  Camdas: An automated conformational analysis system using molecular dynamics , 1997, J. Comput. Aided Mol. Des..

[23]  P B Bradley,et al.  International Union of Pharmacology. XII. Classification of opioid receptors. , 1996, Pharmacological reviews.

[24]  M. Millan.  κ-Opioid receptors and analgesia , 1990 .

[25]  G. Pasternak,et al.  Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype. , 1989, The Journal of pharmacology and experimental therapeutics.

[26]  R. Zukin,et al.  Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Hudlický,et al.  Selective reduction of α,β-unsaturated esters in the presence of olefins , 1987 .

[28]  J. Mccall,et al.  [3H]U-69593 a highly selective ligand for the opioid κ receptor , 1985 .

[29]  R. Lahti,et al.  Properties of a selective kappa agonist, U-50,488H. , 1982, Life sciences.

[30]  P. von Voigtlander,et al.  Benzeneacetamide amines: structurally novel non-m mu opioids. , 1982, Journal of medicinal chemistry.

[31]  A. Beckett.  ANALGESICS AND THEIR ANTAGONISTS: SOME STERIC AND CHEMICAL CONSIDERATIONS , 1956, The Journal of pharmacy and pharmacology.

[32]  A H BECKETT,et al.  SYNTHETIC ANALGESICS: STEREOCHEMICAL CONSIDERATIONS , 1954, The Journal of pharmacy and pharmacology.